Events

AiViva BioPharma is excited to present posters at The Association for Research in Vision & Ophthalmology (ARVO) conference in Salt Lake City, Utah on May 6, 2025. Presentation Number - Posterboard Number: 3782 - B0003 Translation Abstract/Presentation Title:  Periocular Administration of AIV007 Demonstrates Depot Formation for Prolonged Drug Release in Rabbits and Humans Presentation Type:…

We’re excited to announce that AiViva BioPharma will participate in the BIO International Convention 2025, which will take place this June in Boston! With three clinical-stage programs and our proprietary JEL® long-acting injectable platform, AiViva is redefining how therapies are delivered. It focuses drugs precisely where needed, minimizing systemic exposure, and extending duration for up…

AiViva attending the 2025 OIS RETINA INNOVATION SUMMIT, located in Long Beach, California. Date of event is July 29, 2025.      

Where collaboration is driven by a deep sense of commitment to learn and share game-changing therapies in ophthalmology, Ophthalmology Innovation Source (OIS) gives the opportunity to network where extraordinary things happen when the right people connect! Join AiViva at OIS as our CEO, Dr. Diane Tang-Liu, as she presents “AIV007 in nAMD and DME Results”…

AiViva BioPharma is pleased to join Octane Aesthetics Tech Forum this January 8–9, 2026 in Newport Beach as a Presenting Company.  Diane Tang-Liu, CEO and President, is AiViva’s representative as well as Agustin de la Calle, Vice President of Business Development. We look forward to discussions around AIV001, a clinical-stage dermatology program currently under evaluation…